What Clinicians Should Know About Hypertension Management Hypertension remains one of the leading modifiable risk factors for cardiovascular disease worldwide. While orthodox medications remain …
Why We Are Building a Patient-Facing ECS Platform
Part 6, the final in the series: A Changing Landscape in Health and Healing Over the previous pieces, I explored the growing complexity surrounding cannabinoid medicine from several perspectives: …
Read More about Why We Are Building a Patient-Facing ECS Platform →
The ECS as a Framework for Understanding Health and Healing
Why the ECS may help bridge physiology, lived experience, and individualized care Part 5 of the series: A Changing Landscape in Health and Healing Why We Need Better Frameworks for Understanding …
Read More about The ECS as a Framework for Understanding Health and Healing →
The ECS and Sexually Transmitted Infections (STIs): An Emerging Area of Research
CannaKeys Clinical Brief #1 The endocannabinoid system (ECS) and sexually transmitted infections (STIs) represent a novel area of research at the intersection of immunology, inflammation, and …
Read More about The ECS and Sexually Transmitted Infections (STIs): An Emerging Area of Research →
When the Wrong Question Leads to the Wrong Conclusion
A closer look at cannabinoids, mental health, and what the evidence actually says Large meta-analyses often inspire confidence. Researchers combine numbers, calculate outcomes, and draw conclusions …
Read More about When the Wrong Question Leads to the Wrong Conclusion →
Saffron and the Endocannabinoid System
A Regulatory Approach to Inflammation, Mood, and Immune Balance Most people think of the endocannabinoid system (ECS) as CB1 and CB2 receptors, their endogenous ligands, and the enzymes that …
